A Phase 1 Study of CX1003 (Kanitinib) in Patients with Advanced Solid Tumors
A Phase 1 Study of CX1003 (Kanitinib) in Patients with Advanced Solid Tumors
Recruiting · NCT04093466 · Registry updated 2024-10-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1 Study of CX1003 (Kanitinib) in Patients with Advanced Solid Tumors | Advanced Solid Tumor | Recruiting | Phase 1 | 2024-10-17 | NCT04093466 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Beijing Konruns Pharmaceutical Co., Ltd. | 9 |
| Beijing Tongren Hospital | 60 |
| Chinese Academy of Medical Sciences | 36 |
| West China Hospital | 359 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College | Beijing | China | 11 |